Company · CIK 1840439
Biomea Fusion, Inc.
| CIK | 1840439 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | BMEA (Nasdaq) |
| First annual or quarterly report | 2021-05-27 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-289262 | 2025-08-05 | 2026-09-22 | 5 | |
| 333-267884 | 2022-10-14 | 2025-06-18 | 7 | |
| 333-254793 | 2021-03-26 | 2021-04-19 | 5 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-22 | 424B5Shelf takedown | 333-289262 | 0001193125-26-397909 |
| 2025-10-07 | 424B5Shelf takedown | 333-289262 | 0001193125-25-233589 |
| 2025-10-06 | 424B5Shelf takedown | 333-289262 | 0001193125-25-232037 |
| 2025-08-15 | EFFECTDeclared effective | 333-289262 | 9999999995-25-002637 |
| 2025-08-05 | S-3Shelf registered | 333-289262 | 0000950170-25-103144 |
| 2025-06-18 | 424B5Shelf takedown | 333-267884 | 0001193125-25-142828 |
| 2025-06-17 | 424B5Shelf takedown | 333-267884 | 0001193125-25-142132 |
| 2023-03-30 | 424B5Shelf takedown | 333-267884 | 0001193125-23-085519 |
| 2023-03-29 | 424B5Shelf takedown | 333-267884 | 0001193125-23-082849 |
| 2022-11-25 | 424B5Shelf takedown | 333-267884 | 0001193125-22-292548 |
| 2022-10-24 | EFFECTDeclared effective | 333-267884 | 9999999995-22-003124 |
| 2022-10-14 | S-3Shelf registered | 333-267884 | 0001193125-22-262931 |
| 2021-04-19 | 424B4Final prospectus | 333-254793 | 0001193125-21-119607 |
| 2021-04-15 | EFFECTDeclared effective | 333-254793 | 9999999995-21-001452 |
| 2021-04-15 | S-1/AAmendment | 333-254793 | 0001193125-21-117175 |
| 2021-04-12 | S-1/AAmendment | 333-254793 | 0001193125-21-112498 |
| 2021-03-26 | S-1Registration filed | 333-254793 | 0001193125-21-096737 |
| 2021-02-12 | DRSDraft made public | 377-04224 | 0000950123-21-002023 |